Connect with us
DAPA Banner
DAPA Coin
DAPA
COIN PAYMENT ASSET
PRIVACY · BLOCKDAG · HOMOMORPHIC ENCRYPTION · RUST
ElGamal Encrypted MINE DAPA
🚫 GENESIS SOLD OUT
DAPAPAY COMING

Business

TDVG: Still A Buy But Losing Momentum

Published

on

SCHD: 3 Reasons Why I'm Buying More Right Now (NYSEARCA:SCHD)
Continue Reading
Click to comment

You must be logged in to post a comment Login

Leave a Reply

Business

Lam Research: A Strong Buy Built On Memory, Packaging And AI Complexity (NASDAQ:LRCX)

Published

on

Lam Research: A Strong Buy Built On Memory, Packaging And AI Complexity (NASDAQ:LRCX)

This article was written by

My background is in Financial Engineering and I have long since been interested in analyzing strong solid companies with a rare financial Profile. My primary area of specialization is in quantamental analysis, where I use a combination of data driven models and fundamental research. My approach is centered on a structured process that combines top-down screening with bottom-up company specific analysis .I write on to share ideas with a wider audience and also learn more about companies and other analysts. My goal is to make unique ideas & research accessible to retail and professional investors alike, while maintaining analytical depth and a clear investment thesis.Associated with another author Kennedy Njagi

Analyst’s Disclosure: I/we have a beneficial long position in the shares of LRCX either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Advertisement
Continue Reading

Business

The importance of the co-operatives and mutuals to the Welsh economy

Published

on

Business Live

Chief executive of Cwmpas Bethan Webber says this year’s co-operatives fortnight is a moment to celebrate the businesses already showing what is possible

Chief executive of Cwmpas Bethan Webber

.People’s experience of the economy is complex and often disconnected from headline growth. Economies can expand while communities remain fragile. Investment may flow in, but little wealth stays local.

Jobs can be created without giving workers real security, a meaningful voice or a genuine stake in success.

That is why during this year’s co-operatives fortnight(which runs to July 3rd) , we are focusing on a different economic vision for Wales: one that has community wealth building at the heart.

It asks a simple but powerful question: how can we support all communities and places to create wealth, and ensure that more of it stays in that place, circulates through local communities, and benefits the people who live and work there?

Advertisement

It is not a slogan, and it is not a rejection of wider investment. Foreign direct investment will continue to matter and be a catalyst for growth. But if we want a more resilient, productive and inclusive economy, we also need to pay closer attention to local enterprise, democratic ownership and fair work.

In other words, community wealth building is about redesigning the architecture of the Welsh economy. Who owns businesses? Where do profits go? How are public contracts used? Are local firms supported to grow? Do workers share in success? Are communities simply consulted, or are they active participants?

These questions are at the heart of the co-operative movement but are relevant beyond it too.

They matter to entrepreneurs who want to build Welsh businesses across the board. They matter to public bodies who want more value from spending. They matter to investors who understand that resilient local economies are good places to do business. They matter to workers, families and communities who want growth to feel real in their everyday lives.

Advertisement

Wales is a small nation with strong communities, a proud tradition of co-operation, and enormous economic potential. But we also face long-standing challenges, not least stubborn poverty, low productivity, regional inequality, and a loss of wealth from local economies.

Community wealth building gives us a practical way of responding to those challenges. It asks us to move from an economic development model that too heavily relies on attracting activity from outside, towards one that also grows capacity from within.

That means supporting Welsh entrepreneurs. It means helping locally-rooted businesses scale. It means using procurement to strengthen Welsh supply chains. And crucially for us at Cwmpas, it means backing co-operative and social business models that also keep ownership and decision-making closer to the people and places where economic value is created.

Co-operatives, employee-owned businesses and social enterprises are central to this because they change the relationship between business success and community benefit.

Advertisement

The co-operative and mutual Economy 2025 report identifies 519 co-operatives in Wales, with around £500m in income. Wales leads the UK for co-operative new-starts per person. In the wider social economy, Wales now has more than 3,100 social businesses, with a turnover of up to £5.7bn each year and employing up to 68,000 people – with our mapping data showing that 84% pay the Real Living Wage to all staff.

A powerful example of what success looks like is Dulas, a worker-owned co-operative based in Machynlleth. Dulas exports solar-powered vaccine refrigerators to more than 80 countries, helping protect life-saving vaccines in some of the hardest-to-reach communities in the world. In 2024, it was named SME Exporter of the Year at the Wales Business Awards.

This shows what co-operative success can look like – locally rooted and globally relevant. It proves that Welsh-owned enterprises can innovate, export, create skilled jobs and make a huge impact without losing their connection to place.

Since 2020, Wales has seen the number of employee-owned businesses grow from 34 to more than 100. That growth shows what can happen when a clear ambition is matched with specialist support and market development. Instead of successful Welsh firms being sold to distant owners when the owner is reaching retirement, it keeps them rooted and anchored in Wales. It protects jobs, shares wealth, and supports passionate entrepreneurs to leave a legacy in the places that mean so much to them.

Advertisement

We can already see the benefits in businesses such as BIC Innovation, which has seen its employee numbers more than triple since becoming employee-owned.

We have a strong platform for growth, but Wales has not yet fully realised its co-operative potential. A community wealth building approach can make these questions central to economic policy.

As part of a new and integrated approach, it would complement other economic development, improving the Welsh economy from the bottom-up, in a way that strengthens local ownership, builds Welsh supply chains, improves job quality and gives communities a greater stake. That is the rebalancing Wales needs.

Cwmpas believes this is now one of the most important economic opportunities facing Wales. We need to move from celebrating individual examples to building the infrastructure that allows many more to emerge, consistently and across the country.

Advertisement

That means specialist business support and market development. It means better access to finance, stronger links between public procurement and local enterprise, and a clearer role for co-operative and employee-owned models in national economic strategy.

This year’s c-operatives fortnight is a moment to celebrate the businesses already showing what is possible. But it should also be a moment to think bigger. If we want growth that lasts, wealth that stays, and communities that have real power over their economic future, community wealth building must become central to how Wales thinks about prosperity.

The task now is to turn that principle into practice.

Advertisement
Continue Reading

Business

Record defence export deal puts Australia on the radar

Published

on

Record defence export deal puts Australia on the radar

Australia has struck its largest defence export deal under a $2.5 billion agreement to provide Canada with world-leading radar technology.

Continue Reading

Business

UPS to invest $48 million in cold facilities amid GLP-1 boom

Published

on

UPS to invest $48 million in cold facilities amid GLP-1 boom

United Parcel Service (UPS) trucks are parked at a UPS drop yard on Oct. 28, 2025 in Vernon, California.

Mario Tama | Getty Images

United Parcel Service is investing $48 million in 27 temperature‑controlled facilities as the industry sees a boom in healthcare logistics, CNBC has learned exclusively.

Advertisement

The facilities, located across the Americas, Europe and Asia, are optimized for moving around shipments that need to be kept at certain temperatures. The company said the investment will help it stay ahead of a boom in medicines and pharmaceuticals — like some GLP-1s — that have to be kept at certain temperatures by improving speed and end-to-end chain of custody.

“Our global cross-dock facilities strengthen our end-to-end cold-chain capabilities to ensure critical treatments are delivered safely and reliably to patients around the world,” said Kate Gutmann, UPS’ president of international, healthcare and supply chain solutions. “This effort – and all of our work in healthcare logistics – extends from a deep understanding that we’re doing more than moving packages.”

The demand for temperature-sensitive biologics is projected to grow at an 8.3% compound annual growth rate through 2033 and reach a market value of roughly $39.1 billion, according to Growth Market Reports. Many new medicines are required to be stored at specific temperatures to maintain efficacy, UPS said, making healthcare logistics more crucial than before.

According to the World Health Organization, up to 50% of global vaccines are wasted every year, with a significant portion of that coming from cold-chain storage issues.

Advertisement

“These investments reflect our commitment to continue to align our leading end-to-end supply chain to protect innovative treatments and diagnostics, supporting better patient outcomes,” UPS Healthcare President John Bolla said in a statement.

UPS’ move comes as the industry overall has seen growing investments in the space, especially with the meteoric rise of GLP-1 drugs. Medicines like Novo Nordisk‘s Wegovy and Ozempic require strict refrigeration and temperature control during transit. A November KFF poll found that 1 in 8 Americans are taking GLP-1s.

UPS CEO Carol Tomé said on the company’s first-quarter earnings call in April that healthcare remains one of the company’s top priorities and biggest areas of growth.

“Our global healthcare portfolio has gained market share every year since 2021,” she said on the call. “And in the first quarter of this year, we generated our first $3 billion healthcare revenue quarter ever, with all three of our segments delivering year-over-year revenue growth.”

Advertisement

Tomé added that UPS is committed to continuing to “lean into that space in a meaningful way.”

Choose CNBC as your preferred source on Google and never miss a moment from the most trusted name in business news.
Continue Reading

Business

Summit Therapeutics: High-Volatility, Catalyst-Driven Binary Bet (NASDAQ:SMMT)

Published

on

Summit Therapeutics: High-Volatility, Catalyst-Driven Binary Bet (NASDAQ:SMMT)

This article was written by

I would describe myself as a barbell investor focused on two ends of the risk spectrum: relatively safe, income-generating investments on one side, and high-risk, high upside opportunities—primarily binary healthcare and biotech bets—on the other. Professionally, I work as an R&D researcher in the pharmaceutical industry. Combined with my background in economics and self-training in finance, this provides me with unique perspective when evaluating biotech companies. My research spans multiple dimensions of the sector, including platform technologies, IP and freedom-to-operate considerations, mechanistic feasibility, competitive landscapes, binary clinical trial readouts and corporate financials. As an individual investor, I place significant emphasis on valuation, risk management and capital allocation. On the income-investing side of the portfolio, I actively follow dividend paying stock picks, including preferred shares, REITs, BDCs and option-based income ETFs. The objective is to build a durable stream of cash flow that can support moonshot bets on the other side of the barbell. Through my writing on Seeking Alpha, I aim to share independent, research-driven investment ideas from both ends of this barbell approach. My goal is to combine scientific insight, fundamental analysis and risk management to encourage disciplined trading and develop well-grounded investment thesis.

Analyst’s Disclosure: I/we have a beneficial long position in the shares of SMMT either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Advertisement
Continue Reading

Business

Form 4 The York Water Company For: 22 June

Published

on


Form 4 The York Water Company For: 22 June

Continue Reading

Business

The long tail of Trump’s trade agenda

Published

on

The long tail of Trump’s trade agenda

Industry experts say the latest proposals are designed to outlast court challenges, political cycles and administrations. 

Continue Reading

Business

Schwebel Baking set to shut down

Published

on

Schwebel Baking set to shut down

Longtime commercial baker to wind down operations over the summer.

Continue Reading

Business

Occidental Offers A 25% Upside At $70 Oil

Published

on

Occidental Offers A 25% Upside At $70 Oil

Occidental Offers A 25% Upside At $70 Oil

Continue Reading

Business

Amazon Prime Day expected to drive $26.3 billion in online sales

Published

on


Amazon Prime Day expected to drive $26.3 billion in online sales

Continue Reading

Trending

Copyright © 2025